Zhou Y - Search Results

1

Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.

Ren X, Duan L, He Q, Zhang Z, Zhou Y, Wu D, Pan J, Pei D, Ding K. Ren X, et al. Among authors: zhou y. ACS Med Chem Lett. 2010 Sep 7;1(9):454-9. doi: 10.1021/ml100146z. eCollection 2010 Dec 9. ACS Med Chem Lett. 2010. PMID: 24900231 Free PMC article.

2

Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells.

Gao Y, Zhou Y, Xu A, Wu D. Gao Y, et al. Among authors: zhou y. Biol Pharm Bull. 2008 Sep;31(9):1716-22. doi: 10.1248/bpb.31.1716. Biol Pharm Bull. 2008. PMID: 18758065 Free article.

3

Inhibitory effects of A-769662, a novel activator of AMP-activated protein kinase, on 3T3-L1 adipogenesis.

Zhou Y, Wang D, Zhu Q, Gao X, Yang S, Xu A, Wu D. Zhou Y, et al. Biol Pharm Bull. 2009 Jun;32(6):993-8. doi: 10.1248/bpb.32.993. Biol Pharm Bull. 2009. PMID: 19483304 Free article.

4

High level expression, purification and characterization of active fusion human C1q and tumor necrosis factor related protein 2 (hCTRP2) in Escherichia coli.

Li H, Gao X, Zhou Y, Li N, Ge C, Hui X, Wang Y, Xu A, Jin S, Wu D. Li H, et al. Among authors: zhou y. Protein Expr Purif. 2011 Sep;79(1):1-6. doi: 10.1016/j.pep.2011.03.013. Epub 2011 Mar 29. Protein Expr Purif. 2011. PMID: 21453774 Review.

5

Platelet CFTR inhibition enhances arterial thrombosis via increasing intracellular Cl^- concentration and activation of SGK1 signaling pathway.

Yang HY, Zhang C, Hu L, Liu C, Pan N, Li M, Han H, Zhou Y, Li J, Zhao LY, Liu YS, Luo BZ, Huang XQ, Lv XF, Li ZC, Li J, Li ZH, Wang RM, Wang L, Guan YY, Liu CZ, Zhang B, Wang GL. Yang HY, et al. Among authors: zhou y. Acta Pharmacol Sin. 2022 Oct;43(10):2596-2608. doi: 10.1038/s41401-022-00868-9. Epub 2022 Mar 3. Acta Pharmacol Sin. 2022. PMID: 35241769 Free PMC article.

6

Increased intracellular Cl^- concentration mediates neutrophil extracellular traps formation in atherosclerotic cardiovascular diseases.

Han H, Liu C, Li M, Wang J, Liu YS, Zhou Y, Li ZC, Hu R, Li ZH, Wang RM, Guan YY, Zhang B, Wang GL. Han H, et al. Among authors: zhou y. Acta Pharmacol Sin. 2022 Nov;43(11):2848-2861. doi: 10.1038/s41401-022-00911-9. Epub 2022 May 5. Acta Pharmacol Sin. 2022. PMID: 35513433 Free PMC article.

7

Identification of prosaposin as a novel interaction partner for Rhox5.

Guo F, Huang X, Li S, Sun L, Li Y, Li H, Zhou Y, Chu Y, Zhou T. Guo F, et al. Among authors: zhou y, zhou t. J Genet Genomics. 2007 May;34(5):392-9. doi: 10.1016/S1673-8527(07)60042-3. J Genet Genomics. 2007. PMID: 17560524

8

Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.

Wu K, Huang Z, Zhong Z, Liao H, Zhou Y, Luo B, Zhang B. Wu K, et al. Among authors: zhou y. Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):800-809. doi: 10.1002/ccd.28093. Epub 2019 Jan 28. Catheter Cardiovasc Interv. 2019. PMID: 30690863

9

[Study on the biology feature and pathogenicities to silkworm of a microsporidium isolated from Barathra brassicae L].

Zheng X, Zhou Y, Huang B, Lu K, Huang X. Zheng X, et al. Among authors: zhou y. Wei Sheng Wu Xue Bao. 2000 Oct;40(5):540-4. Wei Sheng Wu Xue Bao. 2000. PMID: 12548768 Chinese.

10

Quantifying intratumoral heterogeneity within sub-regions to predict high-grade patterns in clinical stage I solid lung adenocarcinoma.

Zuo Z, Deng J, Ge W, Zhou Y, Liu H, Zhang W, Zeng Y. Zuo Z, et al. Among authors: zhou y. BMC Cancer. 2025 Jan 9;25(1):51. doi: 10.1186/s12885-025-13445-0. BMC Cancer. 2025. PMID: 39789523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,398 results

Search Page

Filters